Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Veracyte, Inc.
VCYT
$25.11
Name : Veracyte, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $2,026,263,552.00
EPSttm : 1.54
finviz dynamic chart for VCYT
Veracyte, Inc.
$25.11
4.36%
$1.05
VCYT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

12.07

Margin Of Safety %

80

Put/Call OI Ratio

0.56

EPS Next Q Diff

0.01

EPS Last/This Y

0.17

EPS This/Next Y

-0.22

Price

25.09

Target Price

47.2

Analyst Recom

1.46

Performance Q

-41.06

Upside

-19.8%

Beta

2.03

Ticker: VCYT




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-13VCYT43.140.890.146712
2026-10-14VCYT43.490.892.676716
2026-10-15VCYT44.360.900.086739
2026-10-16VCYT43.160.90207.006718
2026-10-19VCYT43.80.620.085435
2026-10-20VCYT44.830.623.005444
2026-10-21VCYT46.250.650.505540
2026-10-22VCYT46.110.657.795552
2026-10-23VCYT47.980.760.045994
2026-10-26VCYT48.220.770.275982
2026-10-27VCYT50.490.760.265983
2026-10-28VCYT50.310.810.465846
2026-10-29VCYT52.20.800.305854
2026-10-30VCYT49.990.810.885843
2026-11-02VCYT49.070.810.045826
2026-11-03VCYT50.30.801.215847
2026-11-04VCYT52.520.691.545489
2026-11-05VCYT23.980.640.336465
2026-11-06VCYT24.150.771.746547
2026-11-09VCYT25.930.700.136263
2026-11-10VCYT24.020.560.206936
2026-11-11VCYT25.090.560.156912
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-13VCYT43.12-19.5-15.21.91
2026-10-14VCYT43.50-19.5-11.81.91
2026-10-15VCYT44.37-19.5-9.41.91
2026-10-16VCYT43.16-19.5-16.01.91
2026-10-19VCYT43.78-19.5-11.01.91
2026-10-20VCYT43.78-19.5-11.01.91
2026-10-21VCYT44.81-19.5-8.11.91
2026-10-22VCYT46.08-19.5-13.11.91
2026-10-23VCYT47.92-19.5-8.11.91
2026-10-26VCYT48.24-19.5-12.01.91
2026-10-27VCYT50.42-19.7-7.41.91
2026-10-28VCYT50.30-19.7-7.81.91
2026-10-29VCYT52.17-19.7-8.51.91
2026-10-30VCYT49.99-19.7-17.61.91
2026-11-02VCYT49.06-19.7-14.81.91
2026-11-03VCYT50.29-19.7-12.11.91
2026-11-04VCYT52.52-19.7-7.71.91
2026-11-05VCYT23.92-19.7-75.61.91
2026-11-06VCYT24.00-19.74.01.91
2026-11-09VCYT25.90-19.7-6.01.91
2026-11-10VCYT24.06-24.1-23.81.95
2026-11-11VCYT25.09-24.7-9.61.95
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-13VCYT-13.903.5612.90
2026-10-14VCYT-13.903.5612.90
2026-10-15VCYT-13.903.5612.90
2026-10-16VCYT-13.903.5612.90
2026-10-19VCYT-13.902.7812.90
2026-10-20VCYT-13.902.7812.90
2026-10-21VCYT-14.002.7812.90
2026-10-22VCYT-14.002.7812.90
2026-10-23VCYT-14.002.7812.90
2026-10-26VCYT-14.002.8012.90
2026-10-27VCYT-14.002.8012.44
2026-10-28VCYT-14.002.8012.44
2026-10-29VCYT-15.472.8012.44
2026-10-30VCYT-15.472.8012.44
2026-11-02VCYT-15.473.1312.44
2026-11-03VCYT-15.473.1312.44
2026-11-05VCYT-15.473.1312.44
2026-11-06VCYT-15.473.1312.44
2026-11-09VCYT-14.932.9712.40
2026-11-10VCYT-14.932.9712.40
2026-11-11VCYT-14.932.9712.07
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

0.38

Avg. EPS Est. Current Quarter

0.4

Avg. EPS Est. Next Quarter

0.39

Insider Transactions

-14.93

Institutional Transactions

2.97

Beta

2.03

Average Sales Estimate Current Quarter

147

Average Sales Estimate Next Quarter

157

Fair Value

45.09

Quality Score

74

Growth Score

66

Sentiment Score

3

Actual DrawDown %

58.8

Max Drawdown 5-Year %

-68.9

Target Price

47.2

P/E

16.2

Forward P/E

15.59

PEG

P/S

3.48

P/B

1.41

P/Free Cash Flow

12.51

EPS

1.55

Average EPS Est. Cur. Y​

1.95

EPS Next Y. (Est.)

1.73

Target Price Estimates Raised

Target Price Estimates Lowered

3

Profit Margin

21.8

Relative Volume

1.95

Return on Equity vs Sector %

-17.5

Return on Equity vs Industry %

-2.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-9.6
◆ VCYT Healthcare
$25.11
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
9/25
Volume
0/15
Valuation
20/20
TP/AR
4/10
Options
6/10
RSI
28.7
Range 1M
10.5%
Sup Dist
7.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
44 /100
WEAK
Momentum
6/25
Growth
16/30
Estimates
6/20
Inst/Vol
7/15
Options
9/10
EPS Yr
7.8%
EPS NY
-16.1%
52W%
8.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +36.3% upside
Quality
8/30
Valuation
18/30
Growth
10/25
Stability
9/10
LT Trend
1/5
Upside
+36.3%
Quality
74
MoS
80%
VCYT — P/E HistoricalBiotechnology
Veracyte, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 755
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
VCYT

Latest News

—
Caricamento notizie per VCYT…
stock quote shares VCYT – Veracyte Inc. Stock Price stock today
news today VCYT – Veracyte Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte Inc. yahoo finance google finance
stock history VCYT – Veracyte Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading